glp 1 and perimenopause GLP-1 Microdosing for Menopause: A Hormone-Aware Metabolic Framework estrogen and glp 1 Perimenopause
Description
NanoBiT assays were carried out as previously described (28): 24 hours after transfection, cells were incubated in 3 mM glucose for a minimum of 2 hours, detached and resuspended in NanoGlo Live cell substrate (N2012, Promega), 1:20 dilution in HBSS, and seeded onto an opaque white 96-well half-area plate
Both contain the same active ingredient (semaglutide), but they're FDA-approved for different purposes
Richards, P
however, these same studies recognize the added risk of aspiration and regurgitation with their continuation as well (Ushakumari and Sladen 2024
